It has been reported that metformin suppressed NLRP3 inflammasome activation and ameliorated diabetes-accelerated atherosclerosis in apoE−/− mice; meanwhile, it blocked the activation of the NLRP3 inflammasome in macrophages induced by HG through the activation of the AMPK pathway in vitro [105]. Here, NLRP3 is linked to atherosclerosis.